Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited
Share · INE942C01045 (XBOM)
Overview
No Price
Closing Price XBOM 30.10.2025: 462,65 INR
30.10.2025 06:12
Current Prices from Gujarat Themis Biosyn Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
GUJTHEM.NS
INR
30.10.2025 06:12
462,05 INR
-2,55 INR
-0,55 %
XBOM: MSE
MSE
GUJTHEM.BO
INR
30.10.2025 05:54
462,65 INR
-1,95 INR
-0,42 %
Share Float & Liquidity
Free Float 28,17 %
Shares Float 30,7 M
Shares Outstanding 108,97 M
Company Profile for Gujarat Themis Biosyn Limited Share
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
Get up to date insights from finAgent about Gujarat Themis Biosyn Limited

Company Data

Name Gujarat Themis Biosyn Limited
Company Gujarat Themis Biosyn Limited
Website http://www.gtbl.in
Primary Exchange XBOM MSE
ISIN INE942C01045
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Tapas Bhudebendranath Guhathakurata
Market Capitalization 39 Mrd.
Country India
Currency INR
Employees 0,2 T
Address Themis House, Mumbai
IPO Date 2002-01-02
Dividends from 'Gujarat Themis Biosyn Limited'
Ex-Date Dividend per Share
04.09.2025 0,67 INR

Ticker Symbols

Name Symbol
MSE GUJTHEM.BO
NSE GUJTHEM.NS
More Shares
Investors who hold Gujarat Themis Biosyn Limited also have the following shares in their portfolio:
Hércules S.A. - Fábrica de Talheres
Hércules S.A. - Fábrica de Talheres Share
REGENERA INSIGHTS INC.
REGENERA INSIGHTS INC. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025